| Financial Year |
March 31 2023 |
| Monetary Funds |
597,858,833.44 |
| Held-for-trading Financial Assets |
52,107,844.41 |
| Notes Receivable |
-- |
| Accounts Receivable |
21,389,351.28 |
| Advances to Suppliers |
1,178,694.29 |
| Other Receivables |
505,617.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,322,050,471.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,865,782.57 |
| Total Current Assets |
1,998,956,594.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
59,687,004.79 |
| Fixed Assetes |
297,442,557.52 |
| Under-construction Projects |
17,102,885.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
85,569,873.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
29,008,312.20 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,413,941,766.44 |
| Total Assets |
3,412,898,360.86 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
285,243,691.62 |
| Accounts Received In Advance |
1,387,740.87 |
| Employee Compensation Payable |
827,706.85 |
| Taxes Payable |
94,737,507.43 |
| Interest Payable |
-- |
| Dividend Payable |
2,177,927.57 |
| Other payables |
32,476,254.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,666,787.20 |
| Other Current Liabilities |
5,276,788.02 |
| Sub-Total of Current Liabilities |
528,067,156.09 |
| Long-term Loans |
554,723,666.75 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
224,401,890.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
779,125,557.16 |
| Total Liabilities |
1,307,192,713.25 |
| Paid-In Capital(Or Share Stock) |
686,677,113.00 |
| Capital Surplus |
53,331,197.25 |
| Surplus Reserve |
162,875,107.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
406,265,061.06 |
| Minority Stockholder's Interest |
147,675,424.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,958,030,223.41 |
| Owner's Equity（Stockholder's Equity） |
2,105,705,647.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,412,898,360.86 |
